BridgeBio Pharma, Inc. (BBIO)
73.28
+1.61
(+2.25%)
USD |
NASDAQ |
Apr 24, 16:00
73.32
+0.04
(+0.05%)
After-Hours: 20:00
BridgeBio Pharma EPS Diluted (Quarterly) : -0.9964 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
| Insmed, Inc. | -1.538 |
| Eli Lilly & Co. | 7.024 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -194.64M |
| Revenue (Quarterly) | 154.18M |
| Total Expenses (Quarterly) | 347.04M |
| Enterprise Value | 16.36B |
| Gross Profit Margin (Quarterly) | 94.27% |
| Profit Margin (Quarterly) | -126.2% |
| Earnings Yield | -5.16% |
| Normalized Earnings Yield | -5.050 |